Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Larger Is The Persistent Epithelial Defect Management Market Expected To Become By 2029 Compared With Its 2025 Level?
The persistent epithelial defect management market size has experienced rapid expansion in recent years. It is projected to increase from $7.92 billion in 2024 to $9.26 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 17.0%. Historically, this growth was primarily driven by increased research activities, higher demand for hospitals, the rising prevalence of ocular surface disorders, a growing incidence of eye disorders, and an aging population.
The persistent epithelial defect management market is set for substantial expansion in the forthcoming years. This market’s size is anticipated to reach $17.17 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 16.7%. The projected increase during this period stems from factors such as a surge in partnerships and collaborative efforts, greater awareness and educational campaigns, a stronger focus on value-based care, the rising incidence of conditions like diabetes and hypertension, and the adoption of early intervention and management strategies. Prominent trends for the forecast period include advancements in technology, a heightened demand for innovative treatment types, sophisticated treatment modalities, the availability of cutting-edge surgical tools and techniques, and the introduction of novel drugs.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21256&type=smp
Which Drivers Are Impacting The Persistent Epithelial Defect Management Market?
The market for persistent epithelial defect management is anticipated to expand due to the rising occurrence of eye disorders. Eye disorders encompass a wide variety of medical ailments impacting the eyes’ structure, function, or overall health, potentially resulting in impaired vision, discomfort, or blindness. Factors contributing to the widespread presence of eye disorders include an aging global population, extended periods of screen use, and shifts in environmental conditions. Effective management of persistent epithelial defects is crucial for addressing eye disorders, as it facilitates recovery, reduces inflammation, and guards against potential issues like infections or scarring. An example of this trend is observed in December 2024 data from the World Health Organization, an intergovernmental body located in Switzerland, which indicated an overall pooled prevalence of childhood myopia at 5.23% in 2023. Notably, the rate was considerably higher for females at 4.90% compared to males at 3.94%. Consequently, the rising incidence of eye disorders acts as a primary catalyst for the expansion of the persistent epithelial defect management market.
What Are The Emerging Segments Gaining Attention In The Persistent Epithelial Defect Management Market?
The persistent epithelial defect managementmarket covered in this report is segmented –
1) By Disease Type: Epithalial Or Limbal; Inflammatory Disease; Neurotrophic Disease; Other Disease Types
2) By Distribution Channel: Direct Sales; Online Pharmacy; Retail Pharmacy; Hospitals
3) By End User: Hospital Or Clinical Laboratories; Physician Offices; Reference Laboratories; Other End Users
Subsegments:
1) By Epithelial Or Limbal: Limbal Stem Cell Deficiency (LSCD); Limbal Transplantation; Conjunctival Transplantation
2) By Inflammatory Disease: Dry Eye Syndrome; Allergic Conjunctivitis; Uveitis
3) By Neurotrophic Disease: Herpes Simplex Virus (HSV) Keratitis; Diabetic Neuropathy; Neurotrophic Keratopathy
4) By Other Disease Types: Chemical Burns; Trauma-Induced Defects; Congenital Corneal Opacities
Which Trends Are Impacting The Persistent Epithelial Defect Management Market?
Major companies operating in the persistent epithelial defect management market are concentrating on developing innovative therapies, such as secretome therapy, to accelerate healing and improve treatment outcomes for persistent epithelial defects. Secretome therapy involves using bioactive molecules secreted by cells, including proteins, lipids, and extracellular vesicles, to promote tissue repair, modulate immune responses, and treat various diseases. For instance, in April 2023, Kala Pharmaceuticals Inc., a US-based biopharmaceutical company, was granted U.S. Food and Drug Administration (FDA) Fast Track Designation for KPI-012, a human MSC-S therapy specifically for persistent corneal epithelial defect. The drug’s multifactorial mechanism of action seeks to address all underlying etiologies of persistent epithelial defect management by encouraging corneal healing through bioactive molecules such as growth factors, protease inhibitors, and neurotrophic factors.
Which Leading Players Are Enhancing Their Persistent Epithelial Defect Management Market Presence Worldwide?
Major companies operating in the persistent epithelial defect management market are AbbVie Inc., Novartis AG, Johnson & Johnson Vision, RegeneRx Biopharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Alcon Inc., Bausch Health Companies Inc., Hoya Vision Care, Santen Pharmaceutical Co. Ltd., Recordati Rare Diseases Inc., Dompé Farmaceutici S.p.A., Lumenis Ltd., TissueTech Inc., Ocular Therapeutix Inc., Oculus Surgical Inc., Amber Ophthalmics Inc., Noveome Biotherapeutics Inc., OcuNexus Therapeutics Inc., Lux Bio Inc., Eyenovia Inc.
Download The Full Report For Exclusive Market Findings:
What Are The Regional Market Dynamics Impacting The Persistent Epithelial Defect Management Industry?
North America was the largest region in the persistent epithelial defect management market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the persistent epithelial defect management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Persistent Epithelial Defect Management Market Report:
https://www.thebusinessresearchcompany.com/customise?id=21256&type=smp
Browse Through More Reports Similar to the Global Persistent Epithelial Defect Management Market 2025, By The Business Research Company
Defect Detection Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/defect-detection-global-market-report
Epigenetics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report
Poultry Keeping Machinery Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/poultry-keeping-machinery-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model